Clinical Performance of Three Commercial SARS‐CoV‐2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting

During the second year of the COVID-19 pandemic, the use of Rapid Diagnosis Antigen Tests (RDAgTs) for SARS-CoV-2 detection has substantially increased as some of the brands available in the market were certified for clinical use by international regulatory agencies. RDAgTs are a fast and cheap tool...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales-Jadán, Diana, Viteri-Dávila, Carolina, Castro-Rodriguez, Bernardo, Vallejo-Janeta, Alexander Paolo, Rivera-Olivero, Ismar A., Perez, Franklin, Garcia-Bereguiain, Miguel Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294138/
https://www.ncbi.nlm.nih.gov/pubmed/35865818
http://dx.doi.org/10.3389/fcimb.2022.832235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294138/
https://www.ncbi.nlm.nih.gov/pubmed/35865818
http://dx.doi.org/10.3389/fcimb.2022.832235

Ejemplares similares